CBD, HT Premium, Investment, Legal, Medical, News, North America, USA

Fraud case has hemp in the news, unfortunately

Analysis from HempToday, the voice of the global hemp industries.
Share this:
  • 18

With CBD maker CV Sciences (CVS) joining Hemp Inc. last month as the second target of a federal fraud case in the USA, the question resurfaces: How much damage to the industry’s image? Critics have long railed against the entire penny-stock empire-building “strategy” (see: “Wolf of Wall Street” and tack on the subheadline: “Hemp investing for suckers”).

You need to login to view the rest of the content. Please . Not a Member? Join Us

Get Hemp Industry Updates

* indicates required

Do you want event updates?